Sana Biotechnology Inc reports results for the quarter ended in March - Earnings Summary

Sana Biotechnology

08/05/2023 23:05

* Sana Biotechnology Inc  SANA.OQ  reported a quarterly
adjusted
loss of 43 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 45 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sana Biotechnology Inc's reported EPS for the quarter was
a loss
of 43 cents​.
    * The mean earnings estimate of analysts had risen by
about 18.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sana Biotechnology Inc shares had risen by 74.3% this
quarter and gained 44.3% so far this year.
    * The company reported a quarterly loss of $82.12 million.
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 10:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.45          -0.43          Beat
 Dec. 31 2022      -0.51          -0.38          Beat
 Sep. 30 2022      -0.53          -0.45          Beat
 Jun. 30 2022      -0.51          -0.39          Beat